Elemer Piros, Ph.D., Senior Biotechnology Analyst at Rodman & Renshaw, hosted their latest executive conference call. A Discussion on Late Stage Obesity Drugs Featured: Jack Lief, President and CEO, Arena Pharmaceuticals Timothy E. Morris, Vice President, Finance & CFO, Vivus Michael Narachi, President and CEO, Orexigen Therapeutics read more

Listen Now:

Javelin Pharmaceuticals, Inc. hosted a conference call today featuring CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, discussing the Company's quarterly results for the period ending March 31, 2009. read more

Listen Now:

Rodman & Renshaw hosts the latest in a series of medical expert conference calls. The US declared public health emergency over the swine flu outbreak. More than 100 have died in Mexico. Cases were reported in Europe, New Zealand and in the United States (20; 8 of those in NYC). This variant of the flu may respond to antivirals Tamiflu & Relenza. Should it become resistant, or should it become more deadly, it may only be conquered with vaccination. Novavax is the only company that can deliver a vaccine in 3 months. Please join us for a timely discussion with the CEO, Rahul Singhvi The call was hosted by: Elemer Piros, Ph.D. - Senior Biotechnology Analyst read more

Listen Now:

Rodman & Renshaw hosts the latest in a series of medical expert conference calls. Featuring: Oliver Sartor, MD Medical Oncologist, Piltz Professor of Cancer Research Tulane University School of Medicine read more

Listen Now:

Zangani Investor Community(TM) interviews John B. Nano, Chairman, President and Chief Executive Officer of Competitive Technologies, Inc. Mr. Nano discusses CTT's recently approved FDA application regarding the non-invasive pain management technology developed in Italy, and what this means for the future of CTT and it's shareholders. Mr. Nano is a graduate of MIT's Sloan School Executive Program, holds an MBA in Finance from Northeastern University, and a BS in Chemical Engineering from Worcester Polytechnic Institute. read more

Listen Now:

Zangani Investor Community(TM) interviews John B. Nano, Chairman, President and Chief Executive Officer of Competitive Technologies, Inc. Mr. Nano discusses CTT's pending FDA application regarding the non-invasive pain management technology developed in Italy, and how the company is working to commercialize the device within the United States. read more

Listen Now:

Rodman & Renshaw Capital Group, Inc. will hosts a conference call discussing it's investor presentation regarding the proposed combination with Cowen Group, Inc. The call is hosted by Michael Lacovara and David Horin, Rodman?s Chief Executive Officer and Chief Financial Officer, respectively. read more

Listen Now:

Rodman & Renshaw Capital Group, Inc (NASDAQ: RODM - News) (?Rodman?), today announced that it sent a letter to the Board of Directors of Cowen Group, Inc. (NASDAQ: COWN - News) (?Cowen?) proposing a merger transaction in which Cowen shareholders would receive $7.00 per share consisting of 50% cash and 50% Rodman common stock. read more

Listen Now:

Rodman & Renshaw and MedKnowledge host the latest in a series of medical expert conference calls. Featuring: * Christopher James, MD, Senior Biotechnology Analyst * Barry H. Greenberg, MD, Professor of Medicine, Director Advanced Heart Failure Program ( President Heart Failure Society of America, University of California, San Diego UCSD Medical Center ) Dr. Barry Greenberg, Director, Advanced Heart Failure Treatment Program, has distinguished himself as a leading cardiologist. He is a founding member and current President of the Heart Failure Society of America (HFSA). read more

Listen Now:

Javelin Pharmaceuticals, Inc. hosted a conference call today featuring CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, discussing the Company's quarterly results for the period ending September 30, 2008. read more

Listen Now:

Rodman & Renshaw LLC and and MedKnowledge present the latest in a series of medical expert conference calls. Michael G. King, Jr., Senior Biotechnology Analyst, hosts the call featuring: Ken Fujioka, MD - Director, Nutrition & Metabolic Research Center, Scripps Clinic - Del Mar, San Diego read more

Listen Now:

View From The Boneyard: An Analysis of the Pivotal Trials Presented at ASBMR, Including Denosumab, Lasofoxifene, and Odanacatib Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls. Michael G. King, Jr., Senior Biotechnology Analyst, hosts the call featuring: E. Michael Lewiecki, MD - Clinical Assistant Professor, Medicine at University of New Mexico School of Medicine. Director, New Mexico Clinical Research & Osteoporosis Center Michael McClung, MD - Founding Director, Oregon Osteoporosis Center read more

Listen Now:

Zangani Investor Community interviews Cathy Bradshaw, President of Wound Care Innovations, LLC. Cathy discusses a recent agreement between Wound Management Technologies and Dr. Leland Shapiro, MD to conduct studies on their advanced wound care collagen product, CellerateRx(R). read more

Listen Now:

Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls. The call features: ? Harold E. Lebovitz, MD, Professor of Medicine, Division of Endocrinology and Metabolism/Diabetes ? David G. Orloff, MD, Medical Director / Medical & Regulatory Affairs of Medpace, Inc. read more

Listen Now:

Rodman & Renshaw and Med Knowledge present the latest in a series of medical expert conference calls. read more

Listen Now:

Rodman & Renshaw hosts a conference call, with Michael Lacovara and David Horin, Rodman & Renshaw Capital Group?s Chief Executive Officer and Chief Financial Officer, respectively, discussing the Company's quarterly results. About Rodman & Renshaw Capital Group, Inc. Rodman & Renshaw Capital Group, Inc. is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC, Rodman Principal Investments, LLC and Miller Mathis & Co., LLC. read more

Listen Now:

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls. The call was hosted by senior biotechnology analysts Elemer Piros, Ph.D. (pictured right) and Raghuram Selvaraju, Ph.D. Featuring: Lon Schneider, M.D. read more

Listen Now:

Javelin Pharmaceuticals, Inc. hosts a conference call, with CEO, Martin J. Driscoll, and Stephen J. Tulipano, CPA, CFO, discussing the Company's quarterly results for the period ending June 30, 2008. read more

Listen Now:

Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls The call features David G. Orloff, MD, Medical Director / Medical & Regulatory Affairs of Medpace, Inc. read more

Listen Now:

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls. Senior Biotechnology Analyst Michael G. King, Jr. hosts the call, featuring Arthur F. Kavanaugh, MD, Professor of Clinical Medicine, Director, Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California, San Diego. Dr. Arthur Kavanaugh is a Professor of Clinical Medicine and Director at the Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology at the University of California at San Diego. Dr. Kavanaugh?s research interest include innovative strategies for the treatment of patients with rheumatoid arthritis and other rheumatic diseases, prognostic and predictive factors for outcomes in rheumatic diseases and research programs on approaches to various immunologic diseases, particularly novel biologic therapies. Dr. Kavanaugh has authored dozens of publications in manuscripts, chapters and books.

Listen Now: